Excellent products, solutions and systems for clinical cancer diagnostics

Our Story

Back in 2004, at our first labs in Berlin and Bremerhaven in Germany, a group of ambitious biologists started developing our first solutions for immunohistochemistry and in situ hybridization with a shared vision: to contribute to the pace of advanced cancer detection and characterization.

Since then, products from our stand-alone companies: Zytomed Systems, ZytoVision, 42LS and Diagomics have been present in the laboratories around the globe. With respect to our established brands, we are now moving forward, and we are growing together under the brand-new name ZYTOMICS!

ZYTOMICS, as a leading manufacturer and provider of a continuously evolving and comprehensive portfolio of clinical cancer diagnostic products, strives to equip pathologists in public institutions and private labs with products, solutions, and expertise they need to reach a precise and trustworthy cancer diagnosis.

Driven by the belief that every second counts, when patients expect life-changing diagnoses, the ZYTOMICS team commits to maintain the same high-quality products and services since the very start and continues paving the way with innovative solutions in our product portfolio. With this new brand we will achieve even greater things together.

We strive to make the difference, say yes to new scientific adventures, and grow together as one team.

A Deeper Look Inside

• We are a specialist focused on workflows and solutions for cancer diagnostics

• We are a developer and manufacturer of high quality and innovative products and solutions - third party products are complementary to the portfolio

• We have deep scientific and application expertise

• We are »Made in Europe« to ensure high quality and supply chain stability

• We are dedicated to best-in-class service, highest standards of quality and true consultancy

Key Facts